Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 101,525,288
  • Shares Outstanding, K 258,459
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • 60-Month Beta 0.35
  • Price/Sales 10.38
  • Price/Cash Flow 27.12
  • Price/Book 5.83
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 25.61% ( -2.39%)
  • Historical Volatility 15.25%
  • IV Percentile 48%
  • IV Rank 47.55%
  • IV High 34.35% on 01/16/24
  • IV Low 17.69% on 12/26/23
  • Put/Call Vol Ratio 0.60
  • Today's Volume 604
  • Volume Avg (30-Day) 2,311
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 36,621
  • Open Int (30-Day) 41,806

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 30 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 3.66
  • Number of Estimates 11
  • High Estimate 4.01
  • Low Estimate 3.32
  • Prior Year 2.67
  • Growth Rate Est. (year over year) +37.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
391.01 +2.85%
on 04/18/24
420.87 -4.45%
on 04/02/24
-18.34 (-4.36%)
since 04/01/24
3-Month
391.01 +2.85%
on 04/18/24
437.00 -7.98%
on 02/27/24
-31.73 (-7.31%)
since 02/01/24
52-Week
320.01 +25.66%
on 06/01/23
448.40 -10.32%
on 01/30/24
+57.14 (+16.56%)
since 05/01/23

Most Recent Stories

More News
2 Top Growth Stocks to Buy Right Now and Hold Forever

These healthcare stocks can provide enviable long-term portfolio growth.

VRTX : 402.14 (+2.38%)
JNJ : 151.18 (+4.56%)
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.

These three should have a lot of room to run.

AMZN : 179.00 (+2.29%)
MELI : 1,456.51 (-0.15%)
VRTX : 402.14 (+2.38%)
2 Fantastic Growth Stocks to Buy Right Now

Don't overlook these high-growth businesses.

VRTX : 402.14 (+2.38%)
PINS : 40.48 (+21.02%)
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

CRSP : 53.81 (+1.55%)
LLY : 776.75 (-0.56%)
NVO : 129.21 (+0.70%)
VRTX : 402.14 (+2.38%)
VKTX : 76.43 (-3.96%)
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Vertex is broadening its portfolio.

CRSP : 53.81 (+1.55%)
VRTX : 402.14 (+2.38%)
ALPN : 64.60 (+0.02%)
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES

/CNW/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to...

VRTX : 402.14 (+2.38%)
Making Sense of Amazon CEO Andy Jassy's Latest Letter

And that's just part of the interesting news for investors to dig into.

AMZN : 179.00 (+2.29%)
MSFT : 394.94 (+1.44%)
VRTX : 402.14 (+2.38%)
NVDA : 830.41 (-3.89%)
META : 439.19 (+2.10%)
COST : 722.22 (-0.09%)
GOOGL : 163.86 (+0.66%)
SBUX : 74.44 (-15.88%)
MELI : 1,456.51 (-0.15%)
GOOG : 165.57 (+0.56%)
KIRK : 1.9000 (-0.52%)
BA : 171.46 (+2.16%)
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today

Could Vertex's growth story continue?

VRTX : 402.14 (+2.38%)
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now

These stocks could be near major inflection points.

ALPN : 64.60 (+0.02%)
BRK.AX : 0.014 (unch)
XOM : 116.03 (-1.89%)
OXY : 64.45 (-2.56%)
PATH : 19.24 (+1.42%)
VRTX : 402.14 (+2.38%)
3 Cathie Wood Stocks Analysts Like Better Than Tesla

While Ark Invest scoops up Tesla, these three Cathie Wood picks have higher analyst ratings than the struggling EV leader.

TSLA : 179.99 (-1.80%)
ARKK : 43.82 (+0.83%)
CRSP : 53.81 (+1.55%)
RBLX : 36.58 (+2.87%)
PATH : 19.24 (+1.42%)
VRTX : 402.14 (+2.38%)
EA : 128.18 (+1.07%)
TTWO : 142.74 (-0.05%)
META : 439.19 (+2.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 423.05
2nd Resistance Point 415.00
1st Resistance Point 408.57
Last Price 402.14
1st Support Level 394.09
2nd Support Level 386.04
3rd Support Level 379.61

See More

52-Week High 448.40
Last Price 402.14
Fibonacci 61.8% 399.36
Fibonacci 50% 384.21
Fibonacci 38.2% 369.05
52-Week Low 320.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar